Osteomyelitis risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 9: | Line 9: | ||
*[[Diabetes]] | *[[Diabetes]] | ||
*[[Hemodialysis]] | *[[Hemodialysis]] | ||
*Immunocompromised patients | *[[Immunocompromised]] patients | ||
:*Chemotherapy | :*[[Chemotherapy]] | ||
:*HIV infection | :*[[Human Immunodeficiency Virus (HIV)|HIV]] infection | ||
*Tuberculosis infection | *[[Tuberculosis]] infection | ||
*Injected drug use | *Injected drug use | ||
*Poor blood circulation | *Poor blood circulation | ||
*Sickle-cell disease | *[[Sickle-cell disease]] | ||
*Recent trauma | *Recent [[trauma]] | ||
*Orthopedic surgery | *[[Orthopedic surgery]] | ||
==References== | ==References== | ||
Revision as of 17:41, 11 April 2016
|
Osteomyelitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Osteomyelitis risk factors On the Web |
|
American Roentgen Ray Society Images of Osteomyelitis risk factors |
|
Risk calculators and risk factors for Osteomyelitis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nate Michalak, B.A.
Overview
Risk Factors
Risk factors for osteomyelitis include:[1][2][3]
- Diabetes
- Hemodialysis
- Immunocompromised patients
- Chemotherapy
- HIV infection
- Tuberculosis infection
- Injected drug use
- Poor blood circulation
- Sickle-cell disease
- Recent trauma
- Orthopedic surgery
References
- ↑ Lew, Daniel P.; Waldvogel, Francis A. (1997). "Osteomyelitis". New England Journal of Medicine. 336 (14): 999–1007. doi:10.1056/NEJM199704033361406. ISSN 0028-4793.
- ↑ Lew, Daniel P; Waldvogel, Francis A (2004). "Osteomyelitis". The Lancet. 364 (9431): 369–379. doi:10.1016/S0140-6736(04)16727-5. ISSN 0140-6736.
- ↑ Mader, Jon T.; Shirtliff, Mark; Calhoun, Jason H. (1997). "Staging and Staging Application in Osteomyelitis". Clinical Infectious Diseases. 25 (6): 1303–1309. doi:10.1086/516149. ISSN 1058-4838.